Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7mg for macular oedema secondary to retinal vein occlusion

Ophthalmologica

Volumn 233, Issue 1, 2015, Pages 18-26

  Augustin, Albert J ^a   Holz, Frank G ^b   Haritoglou, Christos ^c   Mayer, Wolfgang J ^c   Bopp, Silvia ^e   Scheuerle, Alexander F ^f   Maier, Matthias ^d   Sekundo, Walter ^g   Sandner, Dirk ^h   Shirlaw, Andrew ⁱ   Hattenbach, Lars Olof ^j  

^a STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e Augenklinik Universitaetsallee   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g UNIVERSITY HOSPITAL MARBURG   (Germany)

^h UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

ⁱ KLINIKUM LUDWIGSHAFEN   (Germany)

^j ALLERGAN PLC   (United States)

more..

Author keywords

Dexamethasone intravitreal implant; Macular oedema; Retinal vein occlusion

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE; RANIBIZUMAB; TRIAMCINOLONE; DRUG IMPLANT; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CATARACT; CATARACT EXTRACTION; CENTRAL RETINA VEIN OCCLUSION; CLINICAL PRACTICE; CONJUNCTIVA DISEASE; CONJUNCTIVAL HEMORRHAGE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GERMANY; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; INTRAVITREAL IMPLANT; LASER SURGERY; MACULAR EDEMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; RETINA DEGENERATION; RETINA DETACHMENT; RETINA VEIN OCCLUSION; RETINAL THICKNESS; RETROSPECTIVE STUDY; CLINICAL TRIAL; COMPLICATION; DRUG EFFECTS; DRUG IMPLANT; INTRAVITREAL DRUG ADMINISTRATION; MIDDLE AGED; PHYSIOLOGY; RETREATMENT; VERY ELDERLY; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETREATMENT; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 84928205629     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000368840     Document Type: Article

References (25)

1. Rehak J, Rehak M: Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 2008; 33: 111-131
2. Nehme A, Edelman J: Dexamethasone inhibits high glucose-, TNF-α-, and IL-1β-induced secretion of inflammatory and angiogenic mediators from retinal microvascular pericytes. Invest Ophthalmol Vis Sci 2008; 49: 2030-2038
3. Scholl S, Augustin A, Lowenstein A, Rizzo S, Kuppermann BD: General pathophysiology of macular oedema. Eur J Ophthalmol 2011; 21(suppl 6):S10-S19
4. Haller J, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group: Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010; 117: 1134-1146
5. Haller J, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group: Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve month study results: twelvemonth study results. Ophthalmology 2011; 118: 2453-2460
6. Haller JA, Dugel P, Weinberg DV, Chou C, Whitcup SM: Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edema. Retina 2009; 29: 46-51
7. Gregori NZ, Feuer W, Rosenfeld PJ: Novel method for analyzing snellen visual acuity measurements. Retina 2010; 30: 1046-1050
8. Papathomas T, Tsagkataki M, Kumar I, Kamal A: Safety and efficacy of dexamethasone intravitreal implant in macular edema due to retinal vein occlusions - 1 year follow-up. Poster presented at the 2013 ARVO Congr, Seattle, May 2013
9. Querques L, Querques G, Lattanzio R, Gigante SR, Del Turco C, Corradetti G, Cascavilla ML, Bandello F: Repeated intravitreal dexamethasone implant (Ozurdex) for retinal vein occlusion. Ophthalmologica 2013; 229: 21-25
10. Pommier S, Meyer F: Résultats d'une étude multicentrique de l'implant de dexaméthasone dans l'oedème maculaire des oblitérations veineuses rétiniennes: étude REMIDO. Réalités Ophtalmol 2012; 195: 1-4
11. Dodwell DG, Krimmel DA: Intraocular pressure in patients after multiple Ozurdex implants for retinal vein occlusion. Poster presented at the 2012 ARVO Congr, Fort Lauderdale, May 2012
12. Capone A Jr, Singer MA, Dodwell DG, Dreyer RF, Oh KT, Roth DB, Walt JG, Scott LC, Hollander DA: Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (SHASTA study). Retina 2014; 34: 342-351
13. Ferrini W, Ambresin A: Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting. Klin Monatsbl Augenheilkd 2013; 230: 423-426
14. Coscas G, Augustin A, Bandello F, de Smet MD, Lanzetta P, Staurenghi G, Parravano MC, Udaondo P, Moisseiev E, Soubrane G, Yatziv Y, Loewenstein A: Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol 2014; 24: 1-9
15. Yeh WS, Haller JA, Lanzetta P, Kuppermann BD, Wong TY, Mitchell P, Whitcup SM, Kowalski JW: Effect of duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology 2012; 119: 1190-1198
16. Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG; for the BRAVO Investigators: Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010; 117: 1102-1112
17. SCORE Study Research Group: A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5. Arch Ophthalmol 2009; 127: 1101-1114
18. Royal College of Ophthalmologists: Cataract Surgery Guidelines. Royal College of Ophthalmologists, 2007
19. Ramezani A, Entezari M, Moradian S, Tabatabaei H, Kadkhodaei S: Intravitreal triamcinolone for acute central retinal vein occlusion: a randomized clinical trial. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1601-1606
20. Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi BA, Gangnon RE, Puliafito CA: Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 2004; 122: 1131-1136
21. Campochiaro PA, Brown DM, Pearson A, Chen S, Boyer D, Ruiz-Moreno J, Garretson B, Gupta A, Hariprasad SM, Bailey C, Reichel E, Soubrane G, Kapik B, Billman K, Kane FE, Green K; for the FAME Study Group: Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology 2012; 119: 2125-2132
22. Kuppermann BD, Blumenkranz MS, Haller JA, Williams GA, Weinberg DV, Chou C, Whitcup SM; for the Dexamethasone DDS Phase II Study Group: Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol 2007; 125: 309-317
23. Brown DM, Campochiaro PA, Bhisitkul RB, Ho AC, Gray S, Saroj N, Adamis AP, Rubio RG: Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 2011; 118: 1594-1602
24. Campochiaro PA, Brown DM, Awh CC, Lee SY, Gray S, Saroj N, Murahashi WY, Rubio RG: Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology 2011: 118: 2041-2049
25. Moisseiev E, Goldstein M, Waisbourd M, Barak A, Loewenstein A: Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion. Eye 2012; 27: 65-71